Mitochondrial Dysfunction in Aging and Cancer.
1Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Research Council, 70126 Bari, Italy.
Journal of Clinical Medicine
|November 17, 2019
Summary
Aging and cancer share common mechanisms, particularly involving mitochondrial dysfunction. This review highlights how mitochondrial changes, signaling, and telomere communication link aging to cancer development and progression.
Area of Science:
- Gerontology
- Oncology
- Mitochondrial Biology
Background:
- Aging is a significant risk factor for cancer development.
- Shared biological mechanisms link aging and tumorigenesis.
- Mitochondrial dysfunction is increasingly implicated in both aging and cancer progression.
Purpose of the Study:
- To summarize current knowledge on mitochondria's role in aging and cancer.
- To focus on three key mitochondrial aspects connecting aging and cancer: mitochondrial genome alterations, mitochondria-to-nucleus signaling, and mitochondria-telomere communication.
Main Methods:
- Review of current scientific literature.
- Synthesis of evidence on mitochondrial dysfunction in aging and cancer.
- Focus on specific molecular and cellular pathways.
Main Results:
- Mitochondrial genome mutations and content changes are linked to aging and cancer.
- Mitochondria-to-nucleus signaling pathways are activated in both aging and tumorigenesis.
- A newly discovered communication pathway between mitochondria and telomeres connects aging and cancer.
Conclusions:
- Mitochondrial dysfunction is a central mechanism linking aging and cancer.
- Understanding these mitochondrial pathways offers potential therapeutic targets for age-related cancers.
Related Concept Videos
Mitochondria
19.4K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
19.4K
Electron Transport Chain: Complex I and II
18.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.3K
Mitochondrial Membranes
16.5K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.5K
Adaptive Mechanisms in Cancer Cells
6.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
The Effect of Aging on Tissues
3.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.1K


